dr. plimack on significance of checkmate-025 trial in rcc
Published 7 years ago • 135 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
1:14
dr. choueiri on significance of checkmate-025 study for rcc
-
1:27
dr. elizabeth plimack on consideration regarding nivolumab in rcc
-
4:46
esd of sm1 adenocarcinoma in colon
-
1:06
dr. mckay discusses the checkmate-214 trial in rcc
-
1:06
dr. plimack discusses recent trials in kidney cancer
-
10:24
the typical prognosis of aggressive renal cell cancer
-
58:30
11-10-2022 - sglt2i: evidence and mechanisms for a nephrology-cardiology consensus
-
18:22
mutliparametric mri for solid masses: accurate detection of clear cell renal cell carcinoma
-
1:39
dr. elizabeth plimack on nivolumab in kidney cancer
-
4:05
long-term rcc data with nivolumab
-
1:42
dr. mcdermott on immotion150 trial in rcc
-
1:38
dr. mcdermott on an analysis of the checkmate-214 study in rcc
-
3:52
checkmate 025: phase 3 trial of nivolumab for advanced kidney cancer
-
0:45
dr. choueiri on fda approval of lenvatinib/everolimus in rcc
-
1:22
dr. mcdermott on major findings of efficacy and safety of nivolumab in rcc
-
7:50
sequencing renal cell carcinoma therapies
-
1:37
dr. amin on rationale for checkmate-214 trial in rcc
-
5:06
phase 3 checkmate - 214
-
4:43
nivolumab in renal cell carcinoma
-
7:01
when to start systemic treatment in newly diagnosed rcc
-
2:30
checkmate 214 trial update
-
3:05
metastatic renal cell carcinoma to ampulla